SEC Comment Letter 0000000000-23-009367 to Vigil Neuroscience, Inc. (VIGL) (CIK 0001827087)
Vigil Neuroscience, Inc. (VIGL) (CIK 0001827087)
Date: Aug. 25, 2023 · CIK: 0001827087 · Accession: 0000000000-23-009367
AI Filing Summary & Sentiment
File numbers found in text: 001-41200
Show Raw Text
United States securities and exchange commission logo
August 25, 2023
Jennifer Ziolkowski
Chief Financial Officer
Vigil Neuroscience, Inc.
100 Forge Road, Suite 700
Watertown, MA 02472
Re:Vigil Neuroscience, Inc.
Form 10-K for the fiscal year ended December 31, 2022
Filed March 21, 2023
File No. 001-41200
Dear Jennifer Ziolkowski:
We have limited our review of your filing to the financial statements and related
disclosures and have the following comment. We may ask you to provide us with information so
we may better understand your disclosure.
Please respond to this comment within ten business days by providing the requested
information or advise us as soon as possible when you will respond. If you do not believe our
comment applies to your facts and circumstances, please tell us why in your response.
After reviewing your response to this comment, we may have additional comments.
Form 10-K for the fiscal year ended December 31, 2022
Controls and Procedures, page 112
1.Please confirm that in your future periodic filings, beginning with your September 30,
2023 Form 10-Q, you will clearly disclose your conclusion regarding the effectiveness of
your disclosure controls and procedures pursuant to Item 307 of Regulation S-K. Please
confirm that your disclosure controls and procedures were effective for the past two
quarters.
In closing, we remind you that the company and its management are responsible for the
accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or
absence of action by the staff.
You may contact Jenn Do at (202) 551-3743 or Daniel Gordon at (202) 551-3486 with
any questions.
FirstName LastNameJennifer Ziolkowski
Comapany NameVigil Neuroscience, Inc.
August 25, 2023 Page 2
FirstName LastName
Jennifer Ziolkowski
Vigil Neuroscience, Inc.
August 25, 2023
Page 2
Sincerely,
Division of Corporation Finance
Office of Life Sciences